Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways

BACKGROUND: The mTORC1-inhibitor everolimus shows limited efficacy in treating patients with gastro-entero-pancreatic or pulmonary neuroendocrine tumors (NETs), and poor outcome in patients with malignant pheochromocytoma or hepatic carcinoma. We speculated that any effect may be enhanced by antogon...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: Nölting, Svenja, Maurer, Julian, Spöttl, Gerald, Aristizabal Prada, Elke Tatjana, Reuther, Clemens, Young, Karen, Korbonits, Márta, Göke, Burkhard, Grossman, Ashley, Auernhammer, Christoph J.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2015
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4670204/
https://ncbi.nlm.nih.gov/pubmed/26636335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0143830
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items